Stryker Launches New Tendon Fixation Device System

Stryker’s Trauma & Extremities division has launched its Citrelock Tendon Fixation Device System. The new system provides surgeons a differentiated design via a tendon thread featuring a resorbable technology, known as Citregen, that has unique chemical and...

ACS Advocacy Efforts for Suicide Awareness Underway

Through its Surgeon Well-Being program, the American College of Surgeons (ACS) is working to build awareness about suicide during September, which is National Suicide Awareness and Prevention Month. During September, ACS is releasing several communications for its...

Intermountain Healthcare Postpones Non-Urgent Surgeries and Procedures

Intermountain Healthcare is postponing all non-urgent surgeries and procedures requiring a hospital admission in its trauma and community hospitals, starting September 15, to support ICUs and acute care units and staffing needs.

Encompass Group LLC Awarded Contract with Vizient

Encompass Group LLC has been awarded a contract with Vizient to supply health care apparel uniforms to Vizient members. Effective August 15, 2021, Vizient members can order Encompass Healthcare Apparel directly from Encompass or through their authorized distributor,...

Encompass Group LLC Earns Patent for Airisana Therapeutic Support Surface

Encompass Group LLC Earns Patent for Airisana Therapeutic Support Surface

Encompass Group LLC has received issuance of patent for Airisana as recognized by the U.S. Patent and Trademark Office (USPTO).

Airisana was developed to represent a unique, new approach in alternating pressure and microclimate management that would support care teams by combining many of the best practices devised to prevent healthcare-acquired pressure injuries into one device, according to the Encompass Group website.

“The issuance of a patent for Airisana is important to Encompass Group. It affirms the years of effort we’ve devoted to this game-changing product, and we have several other additional patents currently pending for Airisana. Encompass understands everyday care and this system provides opportunities to support a reduction in pressure injury risks, drives reductions in patient repositioning injuries among staff, and improves clinical efficiencies,” said Michelle Daniels, Encompass Group vice president, product strategy, development and administration. “We’re delighted by how well Airisana has been received by the nursing community.”

Each Airisana system comes with an intuitive soft-touch user control panel that’s quiet enough to ensure a comfortable healing environment and keeps control in the care provider’s hands.

The repeating pressure therapy patterns employed by traditional therapeutic support surfaces increase the probability that a patient’s body can adjust to the process, which can impede healing. Airisana reduces this risk with randomized pressure therapy modes that promote sustained pressure reduction and combine the benefits of multiple pressure therapies into a constantly changing surface a patient’s body doesn’t get used to. Airisana conforms evenly to irregularities such as body contours. This puts the greatest amount of contact between skin and surface and ensures decreased pressure without interfering with patient mobility. With turn-assist reducing friction and shear risk, and reducing caregiver injury, nurses and clinicians can now easily reposition patients as needed.

“While many hospital-acquired conditions (HACs) have decreased, pressure injuries remain a stubborn exception. Contributing factors such as increased acuities, decompensation, increased use of medical devices and patient adaptation all play a role. Airisana puts an important new tool in the caregiving toolbox. Combined with the benefits of its revolutionary design and easy implementation, it helps nurses, clinicians and their institutions battle pressure injuries. Plus, Arisana meets the Encompass mission for patient safety and comfort. We look forward to announcing additional patents soon,” Daniels added.

For more information, visit



Submit a Comment

Your email address will not be published. Required fields are marked *